Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Insiders, hedge funds, and politicians trading Walgreens stock (NDAQ:WBA) in Q4 2023

Published 03/27/2024, 12:23 PM
Updated 03/27/2024, 12:31 PM
© Reuters.  Insiders, hedge funds, and politicians trading Walgreens stock (NDAQ:WBA) in Q4 2023

Quiver Quantitative - $WBA earnings are coming up. Here is a look at recent trades of $WBA by people who might have an edge.

Congress Members of Congress have disclosed trades of $WBA stock 1 times in the last quarter. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $WBA stock by members of Congress: - Representative Michael C. Burgess sold up to $15,000 on 03/01.

Company Insiders Company insiders have disclosed trades of $WBA stock 1 times in the last quarter. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $WBA stock by company insiders:

- TIMOTHY C WENTWORTH bought approximately $242,220.

Institutions Here’s a breakdown of some of the largest recent moves of $WBA stock: - MORGAN STANLEY bought an estimated $89,223,494 of $WBA stock - SESSA CAPITAL IM, L.P. bought an estimated $77,012,714 of $WBA stock - VANGUARD GROUP INC sold an estimated $72,133,613 of $WBA stock - POINT72 ASSET MANAGEMENT, L.P. bought an estimated $52,405,569 of $WBA stock - INVESCO LTD. bought an estimated $41,340,101 of $WBA stock

This article was originally published on Quiver Quantitative

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.